6 Scopus citations

Abstract

The unprecedented spread of highly pathogenic H5N1 viruses since 1996 has had public health and scientific entities scrambling to prepare for a possible pandemic. Central to many of these efforts has been the development of vaccines. As the viruses have continued to spread, however, they have continued to diversify genetically, complicating vaccine strain selection. The key to successful vaccine design is understanding the cross-reactivity between these genetically distinct H5N1 strains. Studies conducted to date show encouraging amounts of cross-reaction and cross-protection between various H5N1 strains, although our ability to predict one based upon the other is poor. Understanding the targets and mechanisms behind this cross-protection should be a key focus of pandemic preparedness.

Original languageEnglish
Title of host publicationVaccines for Pandemic Influenza
PublisherSpringer Verlag
Pages25-40
Number of pages16
Edition1
ISBN (Print)9783540921646
DOIs
StatePublished - 2009

Publication series

NameCurrent Topics in Microbiology and Immunology
Number1
Volume333
ISSN (Print)0070-217X

Fingerprint

Dive into the research topics of 'Antigenic cross-reactivity among H5N1 viruses'. Together they form a unique fingerprint.

Cite this